Pandemics

Pfizer more than doubles price of lifesaving Covid-19 medication Paxlovid as US transitions out of pandemic phase | CNN The price of the lifesaving Covid-19 antiviral medication Paxlovid will more than double as the United States transitions out of the emergency phase of the pandemic, drugmaker Pfizer said Wednesday. Meg Tirrell CNN

The list price, before insurance, will be $1,390 for a five-day course, Pfizer said in a statement. That’s 2.6 times higher than the $530-per-course price paid by the US government, which provided Paxlovid free to patients during the pandemic. The Wall Street Journal first reported the new price.

Britain’s COVID-19 response inquiry enters a second phase with political decisions in the spotlight LONDON (AP) — Britain’s inquiry into the response to the coronavirus pandemic and its impact on the nation entered its second phase Tuesday, with political decision-making around major developments… PAN PYLAS, Associated Press WWTI - InformNNY.com

...

Opinion | This Isn't COVID's Final Act We must keep the virus, and long COVID, center stage Stuart Katz, MD, Alice Perlowski, MD, MA, and Brittany Taylor, MPH medpagetoday

...